Related Experiment Video

Updated: Jul 12, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

Evaluation of the impact of a pharmaceutical care program in children with asthma

G González-Martin1, I Joo, I Sánchez

  • 1Facultad de Química, Departamento de Farmacia, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago, Chile. ggonzale@puc.cl

Patient Education and Counseling
|January 16, 2003
PubMed

Insights

A pharmaceutical care program significantly improved quality of life for children with asthma, enhancing their daily activities, emotions, and symptom management. This asthma education and monitoring program showed positive impacts without altering spirometry results.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacy
  • Health Outcomes Research

Background:

  • Asthma is a prevalent chronic respiratory condition in children, impacting their quality of life.
  • Effective management of pediatric asthma requires comprehensive patient education and monitoring.
  • Existing asthma care may not fully address the multifaceted needs of young patients.

Purpose of the Study:

  • To evaluate the impact of a structured pharmaceutical care program on the quality of life in children with moderate asthma.
  • To assess improvements in asthma knowledge, self-management, and symptom control through pharmacist intervention.
  • To compare outcomes between children receiving pharmaceutical care and those receiving standard treatment.

Main Methods:

  • A randomized controlled trial was conducted in a pediatric outpatient clinic.
  • The intervention group received comprehensive asthma education, pharmacotherapy assessment, and monitoring.
  • The control group received standard asthma care. Quality of life was measured using the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) at baseline, 2, and 9 weeks. Spirometry was performed at the beginning and end of the study.

Main Results:

  • Children in the pharmaceutical care group showed significant improvements in the activities, emotions, and symptoms domains of the PAQLQ compared to the control group.
  • No significant changes in quality of life scores were observed in the control group.
  • No significant differences in spirometric values were found between the groups post-intervention.

Conclusions:

  • A dedicated pharmaceutical care program can substantially enhance the quality of life for pediatric asthma patients.
  • Pharmacist-led asthma education and monitoring are effective strategies for improving patient-reported outcomes.
  • While spirometry did not change, the program positively impacted children's daily functioning and emotional well-being related to asthma.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...